Pérez-Cordón, Alba
Monté-Rubio, Gemma
Sanabria, Angela
Rodriguez-Gomez, Octavio
Valero, Sergi
Abdelnour, Carla
Marquié, Marta
Espinosa, Ana
Ortega, Gemma
Hernandez, Isabel
Rosende-Roca, Maitee
Vargas, Liliana
Mauleón, Ana
Gil, Silvia
Tartari, Juan Pablo
Lomeña, Francisco
Campos, Francisco
Vivas, Assumpta
Gomez-Chiari, Marta
Benaque, Alba
Ruiz, Agustin
Tárraga, Luis
Boada, Mercè
Alegret, Montserrat
,
Aguilera, N.
Berthier, M.
Buendia, M.
Bullich, S.
Cañabate, P.
Cuevas, C.
de Rojas, I.
Gailhajenet, A.
Diego, S.
Giménez, J.
Gismondi, R.
Guitart, M.
Ibarria, M.
Lafuente, A.
Martín, E.
Martínez, J.
Moreno, M.
Moreno-Grau, S.
Núñez, L.
Orellana, A.
Páez, A.
Pancho, A.
Pavía, J.
Pelejà, E.
Pérez-Grijalba, V.
Pesini, P.
Preckler, S.
Romero, J.
Montrreal, L.
Sarasa, M.
Sotolongo-Grau, O.
Tejero, M. A.
Torres, M.
Funding for this research was provided by:
Grifols SA
Life Molecular Imaging
Laboratorios Echevarne
Araclon Biotech
Article History
Received: 14 January 2020
Accepted: 17 September 2020
First Online: 20 October 2020
Competing interests
: Dr. Mercè Boada has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai and Servier. She received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche and Servier. She has not received personal compensations from these organizations. The other authors declare no competing financial interests.